Markets:

Overview

News

Currencies

International

Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

1.925 -0.025 (-1.28%)

Streaming Delayed Price Updated: 10:29 AM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioXcel Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 24, 2025

From Halper Sadeh LLC

Via Business Wire

BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients ↗

September 10, 2025

BioXcel's Phase 3 trial shows BXCL501 effectively reduces agitation in bipolar and schizophrenia patients, supporting its at-home treatment use.

Via Benzinga

BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗

September 10, 2025

Via Stocktwits

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank? ↗

September 02, 2025

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

August 27, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 27, 2025

Via Benzinga

Which stocks are experiencing notable movement on Wednesday? ↗

August 27, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Via Chartmill

BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗

August 27, 2025

Via Stocktwits

BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug ↗

August 27, 2025

Via Stocktwits

BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label ↗

August 18, 2025

Via Stocktwits

BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment ↗

August 27, 2025

BioXcel's Phase 3 trial shows BXCL501 safely reduces agitation in schizophrenia patients, supporting plans for an FDA label expansion.

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

August 27, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗

August 27, 2025

Via Benzinga

BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know ↗

August 27, 2025

BioXcel Therapeutics shares surged over 19% after hours ahead of key Phase 3 trial results for its at-home agitation treatment, sparking strong investor interest.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 26, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

August 26, 2025

As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Tuesday's pre-market session: top gainers and losers ↗

August 19, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!

August 18, 2025

Via AB Newswire

Topics Artificial Intelligence

BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On? ↗

August 18, 2025

BioXcel Therapeutics Inc (NASDAQ:BTAI) shares are trading higher. The AI biopharmaceutical company on Monday announced positive meeting comments from the U.S. Food and Drug Administration (FDA).

Via Benzinga

Topics Artificial Intelligence

These stocks are moving in today's pre-market session ↗

August 18, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 18, 2025

Via Benzinga

Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

August 18, 2025

Via Benzinga

BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label (This works) ↗

August 18, 2025

The update comes as the company wraps up its pivotal Serenity At-Home Phase 3 trial and analysts grow more optimistic on BXCL501’s commercial potential.

Via Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 15, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

August 15, 2025

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

3 Supercharged Stocks Flashing Strong Momentum Signals ↗

August 13, 2025

Here's a look at some standout momentum movers that are just starting to pick up steam.

Via Benzinga

BioXcel Therapeutics (BTAI) Stock Is Extremely Volatile Today: What's Going On? ↗

August 12, 2025

Shares of BioXcel Therapeutics are trading sharply lower Tuesday morning. The company announced its financial results for Q2.

Via Benzinga

Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial

August 12, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:RLYB),(NASDAQ:BTAI),(NYSE:PFE) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

These stocks are moving in today's after hours session ↗

August 11, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.